Norges Bank’s Syneron Medical Ltd ELOS Stock Holding History

Norges Bank’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-335,570	Closed	-$2.4M	–	2285
2015 Q3	$2.4M	Buy	335,570 +142,012	+73%	+$1.36M	﹤0.01%	2008
2015 Q2	$2.06M	Sell	193,558 -35,000	-15%	-$410K	﹤0.01%	2037
2015 Q1	$2.83M	Hold	228,558	–	–	﹤0.01%	2019
2014 Q4	$2.13M	Hold	228,558	–	–	﹤0.01%	2087
2014 Q3	$2.29M	Sell	228,558 -228,558	-50%	-$2.33M	﹤0.01%	2072
2014 Q2	$4.72M	Buy	457,116 +228,558	+100%	+$2.47M	﹤0.01%	2078
2014 Q1	$2.85M	Hold	228,558	–	–	﹤0.01%	1998
2013 Q4	$2.81M	Hold	228,558	–	–	﹤0.01%	2005
2013 Q3	$1.97M	Hold	228,558	–	–	﹤0.01%	2049
2013 Q2	$1.99M	Buy	+228,558	New	+$2.04M	﹤0.01%	2057

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank's ELOS Position: Q4 2015 in Review

Norges Bank sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 335,570 shares — an estimated $2.4M sold.

Norges Bank first reported a position in ELOS in Q2 2013 and held it in 10 quarters. The position peaked at $4.72M in Q2 2014. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

Norges Bank reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
Norges Bank sold 335,570 Syneron Medical Ltd shares in Q4 2015, an estimated $2.4M.
Norges Bank first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 10 quarters.
Norges Bank's Syneron Medical Ltd position peaked at $4.72M in Q2 2014.
57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on Norges Bank's 13F filing for Q4 2015, filed 10 Feb 2016.